ICU Medical, Inc. $ICUI Stock Holdings Lifted by Kirr Marbach & Co. LLC IN

Kirr Marbach & Co. LLC IN increased its holdings in ICU Medical, Inc. (NASDAQ:ICUI) by 18.4% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 44,153 shares of the medical instruments supplier’s stock after buying an additional 6,863 shares during the period. Kirr Marbach & Co. LLC IN’s holdings in ICU Medical were worth $5,702,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. SG Americas Securities LLC boosted its stake in ICU Medical by 117.3% in the first quarter. SG Americas Securities LLC now owns 8,832 shares of the medical instruments supplier’s stock valued at $1,141,000 after acquiring an additional 4,767 shares during the period. Rockefeller Capital Management L.P. raised its position in shares of ICU Medical by 21.6% during the 4th quarter. Rockefeller Capital Management L.P. now owns 823 shares of the medical instruments supplier’s stock worth $117,000 after purchasing an additional 146 shares during the period. Corient Private Wealth LLC lifted its holdings in shares of ICU Medical by 104.8% in the 4th quarter. Corient Private Wealth LLC now owns 8,312 shares of the medical instruments supplier’s stock worth $1,189,000 after purchasing an additional 4,253 shares during the last quarter. Kera Capital Partners Inc. bought a new stake in shares of ICU Medical in the 4th quarter worth approximately $217,000. Finally, Mercer Global Advisors Inc. ADV boosted its position in ICU Medical by 89.9% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 4,815 shares of the medical instruments supplier’s stock valued at $687,000 after purchasing an additional 2,280 shares during the period. Institutional investors and hedge funds own 96.10% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently commented on ICUI shares. Jefferies Financial Group upgraded ICU Medical to a “strong-buy” rating in a research note on Thursday, May 7th. Sanford C. Bernstein downgraded shares of ICU Medical to a “market perform” rating in a report on Monday, June 15th. Needham & Company LLC upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $165.00 price target for the company in a research report on Wednesday, May 27th. Weiss Ratings upgraded shares of ICU Medical from a “sell (d)” rating to a “sell (d+)” rating in a research report on Monday, May 11th. Finally, Piper Sandler reduced their target price on shares of ICU Medical from $178.00 to $163.00 and set an “overweight” rating for the company in a research note on Friday, April 17th. Two equities research analysts have rated the stock with a Strong Buy rating, four have assigned a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $168.40.

Insider Buying and Selling

In other ICU Medical news, Director David C. Greenberg sold 2,424 shares of the stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $122.91, for a total transaction of $297,933.84. Following the completion of the transaction, the director directly owned 7,960 shares of the company’s stock, valued at approximately $978,363.60. This trade represents a 23.34% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, VP Virginia Ruth Sanzone sold 2,447 shares of ICU Medical stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $124.08, for a total value of $303,623.76. Following the transaction, the vice president directly owned 19,460 shares in the company, valued at approximately $2,414,596.80. The trade was a 11.17% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 2.10% of the company’s stock.

ICU Medical Trading Down 0.2%

Shares of ICUI stock opened at $135.82 on Wednesday. ICU Medical, Inc. has a 1 year low of $107.00 and a 1 year high of $160.29. The firm has a market capitalization of $3.39 billion, a PE ratio of 73.42, a price-to-earnings-growth ratio of 1.90 and a beta of 0.77. The stock has a fifty day moving average of $130.36 and a two-hundred day moving average of $138.31. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.17 and a current ratio of 2.34.

ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings results on Thursday, May 7th. The medical instruments supplier reported $1.97 EPS for the quarter, beating analysts’ consensus estimates of $1.78 by $0.19. The company had revenue of $525.77 million for the quarter, compared to analyst estimates of $520.65 million. ICU Medical had a return on equity of 7.50% and a net margin of 2.15%.The company’s quarterly revenue was down 12.3% compared to the same quarter last year. During the same period last year, the company earned $1.72 earnings per share. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. As a group, research analysts expect that ICU Medical, Inc. will post 6.5 EPS for the current year.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.